Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...

Here are three reasons why Pfizer could prove to be a steal of a deal this year. Buying quality stocks at decent valuations ...

When being honest, the guidance is not great, but expectations towards Pfizer are rather low right now. And when looking at the stock price and the intrinsic value (we will get to this ...

We believe the best companies have predictable cash flows and are run by management teams that have a history of making ... patent losses hit in 2028. Pfizer stock is currently trading at a ...

Also Read: This Maharatna company's stumbling stock belies its steady growth. Should you invest? However, the all-or-nothing strategy has taken Pfizer downhill in recent years. To quote its chief ...

Stock splits, particularly in the tech sector, have gained attention in recent months. As stocks such as Nvidia and Broadcom rose above $1,000 per share, they each executed stock splits ...

As of 3:47:02 pm GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

The company announced a stock split of one equity share with a face value of ₹10 per share into 10 equity shares with a face value of Re 1 per share, according to the BSE data. (Stock split ...